Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Safinamide modulates striatal glutamatergic signalling in a rat model of levodopa-induced dyskinesia.

Gardoni F, Morari M, Kulisevsky J, Brugnoli A, Novello S, Pisano CA, Caccia C, Mellone M, Melloni E, Padoani G, Sosti V, Vailati S, Keywood C.

J Pharmacol Exp Ther. 2018 Oct 5. pii: jpet.118.251645. doi: 10.1124/jpet.118.251645. [Epub ahead of print]

2.

Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia.

Morari M, Brugnoli A, Pisanò CA, Novello S, Caccia C, Melloni E, Padoani G, Vailati S, Sardina M.

J Pharmacol Exp Ther. 2018 Feb;364(2):198-206. doi: 10.1124/jpet.117.245100. Epub 2017 Nov 22.

PMID:
29167350
3.

Role of LRRK2 in the regulation of dopamine receptor trafficking.

Rassu M, Del Giudice MG, Sanna S, Taymans JM, Morari M, Brugnoli A, Frassineti M, Masala A, Esposito S, Galioto M, Valle C, Carri MT, Biosa A, Greggio E, Crosio C, Iaccarino C.

PLoS One. 2017 Jun 5;12(6):e0179082. doi: 10.1371/journal.pone.0179082. eCollection 2017.

4.

Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.

Longo F, Mercatelli D, Novello S, Arcuri L, Brugnoli A, Vincenzi F, Russo I, Berti G, Mabrouk OS, Kennedy RT, Shimshek DR, Varani K, Bubacco L, Greggio E, Morari M.

Acta Neuropathol Commun. 2017 Mar 14;5(1):22. doi: 10.1186/s40478-017-0426-8.

5.

Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain.

Rimessi A, Pavan C, Ioannidi E, Nigro F, Morganti C, Brugnoli A, Longo F, Gardin C, Ferroni L, Morari M, Vindigni V, Zavan B, Pinton P.

Neuropsychopharmacology. 2017 Jun;42(7):1491-1501. doi: 10.1038/npp.2017.20. Epub 2017 Jan 27.

6.

Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia.

Brugnoli A, Napolitano F, Usiello A, Morari M.

Neurobiol Dis. 2016 Jan;85:155-163. doi: 10.1016/j.nbd.2015.10.020. Epub 2015 Oct 29.

PMID:
26522958
7.

Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.

Paolone G, Brugnoli A, Arcuri L, Mercatelli D, Morari M.

Mov Disord. 2015 Nov;30(13):1728-38. doi: 10.1002/mds.26326. Epub 2015 Jul 24.

PMID:
26207892
8.

[Patient care in the postoperative period: some questions].

Brugnoli A, Bassetti MA, Natale N, Busetti A.

Riv Inferm. 1990 Oct-Dec;9(4):201-3. Italian. No abstract available.

PMID:
2127132
9.

[Hypnotherapy of pain].

Brugnoli A.

Minerva Med. 1974 Sep 12;65(63):3288-95. Italian. No abstract available.

PMID:
4422563
10.

[Hypnotic therapeutic methods for pain].

Brugnoli A.

Minerva Med. 1974 Jun 20;65(47):2637-41. Italian. No abstract available.

PMID:
4844365
11.

[Hypnotic therapeutic methods for pain].

Brugnoli A.

Minerva Med. 1974 Jun 20;65(47):2637-41. Italian. No abstract available.

PMID:
4422565
12.

[Hypnotherapy in orthopedics and traumatology].

Vannoni S, Brugnoli A.

Minerva Ortop. 1971 Mar;22(3):77-83. Italian. No abstract available.

PMID:
5579742

Supplemental Content

Loading ...
Support Center